GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Total Payout Ratio

ACUS (Acusphere) Total Payout Ratio : -0.01 (As of Sep. 24, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Acusphere Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Acusphere's current Total Payout Ratio is -0.01.


Acusphere Total Payout Ratio Historical Data

The historical data trend for Acusphere's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusphere Total Payout Ratio Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Total Payout Ratio
Get a 7-Day Free Trial 2.18 0.67 1.28 0.97 0.31

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.05 - - -

Competitive Comparison of Acusphere's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Acusphere's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acusphere's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acusphere's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Acusphere's Total Payout Ratio falls into.



Acusphere Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Acusphere's Total Payout Ratio for the fiscal year that ended in Dec. 2007 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 18.834 + -2.275) / -53.73
=0.31

Acusphere's Total Payout Ratio for the quarter that ended in Sep. 2008 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.005 + 0) / -10.284
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acusphere Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Acusphere's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Acusphere Business Description

Traded in Other Exchanges
N/A
Address
99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Executives
Martyn D Greenacre director 41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin director C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm officer: VP Finance C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero other: Former Senior VP/CFO C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell director 950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/ 10 percent owner BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na 10 percent owner 100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp 10 percent owner 100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire director C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154

Acusphere Headlines

No Headlines